The significant decrease in SPINK4 in active stage suggests its potential occurrence during the specific clinical process of acute colitis or the preclinical phase of IBD, particularly UC, which could be attributed to the dramatical depletion of goblet cells during the onset of colitis. Here, SPINK4 is linked to inflammatory bowel disease.